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Abstract

Introduction

For the cell type diagnosis of leukemia in adult patients, particularly when the sampling of bone marrow
is difficult, the study of peripheral blood leukocytes
(PBLs) by immuno-electron microscopy provides significant information, as illustrated here in two cases of hairy
cell leukemia and seven cases tentatively identified as
megakaryoblastic leukemia (M7). Indirect immunogold
labeling with the B-ly7 monoclonal antibody (CD103)
proved valuable in confirming the diagnosis of hairy cell
leukemia. Immunogold labeling for the GplIIa platelet
glycoprotein (CD61) was used in cases where the light
microscopy of blood films revealed possible megakaryoblastic leukemia. Under the electron microscope, however, the CD61 positive cells showed, in almost all
cases, a wide spectrum of megakaryopoietic differentiation which made the diagnosis of M7 questionable.
Most of the CD61 positive cells featured cytoplasmic
differentiation markers such as alpha granules and demarcation membranes, further confirming the presence
of circulating megakaryocythemia, a phenomenon described many years ago in various myeloproliferative
disorders . It is suggested, therefore, that many of these
cases should not be identified as true megakaryoblastic
leukemias.

In adult patients, leukemias are classified in distinct
subtypes which are routinely diagnosed by examination,
under the light microscope, of bone marrow aspirates or
biopsies, and of peripheral blood films. The F AB classification (Bennett et al., 1976, 1985) recognizes seven
myeloid (Ml to M7) and three lymphoblastic (Ll, L2
and L3) forms of the disease.
Thirty years ago, recognizing the various leukemic
subtypes was of questionable redeeming value since
prognosis was invariably fatal. Although precise cell
typing has sometimes been regarded as an academic
exercise, it provides important prognostic information,
since myeloid leukemias follow a more aggressive
course than lymphoblastic disease.
Fortunately, the prognosis of acute leukemias has
been significantly improved over the past decades by :
(1) the progress of chemotherapy, and (2) the refinement
of methods for bone marrow transplantation. However,
the most encouraging results of several therapeutic protocols are, as reported worldwide, cell-type restricted.
For example, alpha-interferon, deoxycoformycin and
2-chlorodeoxyadenosine induce very prolonged remissions in almost ail cases of hairy cell leukemia (HCL),
while the same treatments are apparently of no therapeutic value in other forms of leukemia. In promyelocytic
leukemia (PML, FAB: M3) , all-trans retinoic acid alone
results in significant remissions, while the same therapy
has no effect in other types of leukemias. Obviously,
precise cell typing of acute leukemias is no longer an
academic exercise. It has become an absolute necessity
for the selection of the most appropriate therapy for each
individual case of leukemia.
Precise cell typing can be achieved by several
methods: (1) routine hematology, (2) flow cytometry,
(3) cytogenetics, (4) molecular diagnosis, and (5) ultrastructural characterization of the leukemic cells by electron microscopy. A combination of these methods is
probably the most efficient approach to correct diagnosis, in spite of their relatively poor concordance reported
recently (Choi et al., 1994).
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Figure 1. Two typical hairy cells featuring the characteristic broad based surface projections and several short
microvilli. Their cytoplasm is moderately rich in organelle (mitochondria and rough ER). Nuclei have some margination of heterochromatin and inconspicuous nucleoli.

gy clinic at the Toronto General Hospital allowed us to
select cases in which a diagnosis of hairy cell leukemia
(HCL) or of megakaryoblastic leukemia (M7) was suspected by light microscopy of blood films.
Citrated peripheral blood was collected from these
patients prior to initiation of chemotherapy. Mononuclear cells were separated by centrifugation on FicollHypaque gradients, and prefixed for 10 minutes (not any
longer!) with a solution of phosphate buffered 0. 1 %
glutaraldehyde which will prevent internali?.ation of the
antigen-antibody-gold complexes. All preparatory steps
were at room temperature. When a diagnosis of HCL
was anticipated (2 cases), the mononuclear cells were
incubated for 60 minutes with an undiluted preparation
(110 µg/ml) of the B-ly7 murine monoclonal antibody
(Poppema et al., 1989; Visser et al. , 1989; de Harven
et al., 1994). When a diagnosis of megakaryoblastic
leukemia was suspected (7 cases), the cells were incubated with a 1:50 dilution of the anti-GpIIIa (CD61)
murine monoclonal antibody (Y2/51, Dakopatts,
Glostrup, Denmark). For scanning electron microscopy

The purpose of this paper is to demonstrate that
transmission and scanning immuno-electron microscopy
of peripheral blood leukocytes (PBLs) of leukemic patients provide valuable diagnostic information not readily
obtainable by other methods, particularly when bone
marrow aspiration is difficult or non-diagnostic. This is
frequently the case in hairy cell leukemias (HCL) and in
megakaryoblastic leukemias (M7) with myelofibrosis
(Bennett et al., 1985). The use of immuno-electron microscopy in the study of hairy cell and of megakaryoblastic leukemia is particularly indicated in view of the
absence of cytogenetic markers and the inaccuracy of
flow cytometry for the study of these two diseases. Indeed, flow cytometry can hardly distinguish between
megakaryocyte precursors, giant platelets, and platelet
aggregates.

Materials and Methods
Peripheral blood leukocytes
A close collaboration with the Hematology/Oncolo-
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Figure 2. Indirect immunogold labeling of another hairy cell incubated with the B-ly7 antibody and studied at high
magnification to facilitate the observation of the numerous 5 nm gold markers, frequently seen in small clusters on cell
surface (arrows).

(SEM), cells were attached on poly-I-lysine coated glass
coverslips and dip-rinsed for all preparatory steps,
strictly avoiding any risk of air drying. For transmission electron microscopy (TEM), the cells were incubated in suspension and centrifuged at low speed for
each step. Since indirect immunogold labeling was
used, secondary incubation was with goat anti-murine
IgG 1 adsorbed on 5 nm colloidal gold particles for TEM
and 30 nm colloidal gold particles for SEM (GAM-G5
and GAM-G30, respectively, from Janssen Pharmaceutica, Beerse, Belgium). Dilution of the antibody conjugates depended on gold particle size: 1:20 for the 5
nm, and 1: 10 for the 30 nm size particles. Final fixation was with 2.5 % glutaraldehyde followed by osmium
tetroxide for TEM, and with glutaraldehyde alone for
SEM. Fragments of cell pellet were embedded in Epon/
Araldite for TEM; SEM coverslips were dried at the
critical point of CO 2 and conductive coated with evaporated carbon only. For TEM, a JEOL 1200-EXII
(JEOL-USA, Inc., Peabody, Mass.) was used, at original magnification ranging from 4,000 to 25,000 X. For

SEM, a JEOL 840 instrument was used, fitted with the
standard solid state annular backscattered electron
detector and with a lanthanum hexaboride cathode
(Denka, Mitsui and Co. , Tokyo, Japan). Imaging was
at 15 kV accelerating voltage for both secondary (SE)
and backscattered electron (BE) signals.
More details on the procedures used for immunogold labeling have been previously published (de Harven
and Soligo, 1986, 1989; de Harven et al., 1984).

Results
Hairy cell leukemias
Under the TEM, hairy cells are primarily identified
by their long, "dagger-shaped" surface projections.
These projections are, in most cells, easily distinguished
from surface microvilli by their greater length and by
their diameter which is characteristically larger near the
cell surface than at the tip of the projection. In nearly
50% of the cases (Daniel and Flandrin, 1974), the
cytoplasm features a very distinct structure classically
1193
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Figure 3. Scanning electron micrograph of the hairy cells illustrating the typical ruffling surface morphology. The
gold markers are only faintly recognized in this secondary electron image.

frequently counted on one thin-section of a single cell,
sometime as single markers or as small clusters (Fig. 2).
It is important to note that a few cells with the typical
morphology of hairy cells were clearly unlabeled and
therefore considered as B-ly7 negative. The percentage
of hairy cells varied considerably from one patient to
another. The non-hairy cells were mostly lymphocytes.
Typical monocytes were practically never observed in
the peripheral blood of these patients, confirming a
previous report by Seshardi et al. (1976). An extensive
TEM search for B-ly7 positivity in non-hairy cells of
these two patients remained entirely negative. In one
control TEM experiment with mononuclear cells from a
normal donor, rare lymphocytes were found B-ly7 positive and all monocytes were found negative.
Under the SEM, the florid surface morphology of
hairy cells is striking (Fig. 3). The abundance of ruffles
and long surface projections is diagnostic at first glance.
The clinical importance of this observation has long been
noticed (de Harven and Lampen, 1978). Since the time
interval between collection of the patient's blood and
SEM observation can be as short as three to four hours,

described as "ribosome-lamellae complex" or RLC
(Katayama et al., 1972). The presence of these structures strongly supports a diagnosis of HCL, although
their absence does not rule it out. Moreover, it should
be emphasized that RLC have been described in nonhairy cell diseases. RLC were observed in only one of
the two cases studied here. Other cytoplasmic organelles (mitochondria, Golgi, RER) were unremarkable, although their large number suggested well differentiated
cells, not primitive blasts. With a significant amount of
marginated heterochromatin and small, inconspicuous
nucleoli (Fig. 1), the ultrastructure of the nuclei of hairy
cells did not resemble that of progenitor cells or blasts.
The B-ly7 antibody recognizes an antigen present on
the surface of almost all hairy cells; it has recently been
enclosed in the CD103 cluster (Cepek et al., 1995).
The expression of this antigen as demonstrated by immunolabeling with 5 nm colloidal gold markers was relatively intense, unquestionably above non-specific background. Admittedly, counting gold markers present on
cell surfaces is of limited biological value (de Harven et
al., 1987). Nevertheless, 100-200 gold markers were
1194
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Figure 4. In the backscattered electron imaging mode (reverse polarity), the 30 nm gold markers are unambiguously
identified throughout the cell surface of the same hairy cell as that shown on Figure 3.

reports can reach the clinical hematologists prior to
therapeutic decisions. Of course, processing time is
longer if immunogold labeling is performed. Using the
B-ly7 antibody, most hairy cells were heavily labeled
(Fig. 4) in spite of the low labeling efficiency of 30 nm
gold markers (de Harven and Soligo, 1989). According
to earlier reports (de Harven et al., 1984), and once
more confirmed here, the backscattered electron (BE)
imaging mode of the SEM is, by far, the most efficient
approach to an unambiguous recognition of positively
labeled cell surfaces. Unquestionably, the search for
weakly labeled non-hairy cells would have been very difficult if this investigation had been limited to the use of
the secondary electron (SE) imaging mode. Using the
BE mode, one can clearly state that a few hairy cells
with the typical florid surface morphology were entirely
B-ly7 negative, as already seen in TEM. At variance
with the TEM observations, rare B-ly7 positive cells
with the surface morphology of lymphocytes were observed. This subset of B-ly7 positive cells, obviously
lymphocytes (de Harven et al., 1986), represented about
1 % of the total lymphocyte population in this sample.

However, an extensive search, in the BE imaging mode,
for B-ly7 positive lymphocytes in one control sample
from a normal donor remained entirely negative (230
cells counted).
Megakaryoblastic leukemias (M7)

The study of megakaryoblastic disease has been performed by immuno-TEM, all cells being primed with the
anti-GpIIIa (CD61) monoclonal antibody . GplIIa, a surface glycoprotein known as one portion of the Gpllb/llla
complex, was found expressed on all platelets, all megakaryocytes and many megakaryoblasts. Seven cases in
which the diagnosis of M7 was suspected by light microscopy of peripheral blood films, have been studied
and the observations summarized as follows .
All platelets were heavily labeled and served as a
convenient internal control, ensuring that the Gpllla glycoprotein had been effectively labeled with the immunogold marker in each sample. The labeling density, expressed as the number of 5 nm colloidal gold markers
per 1 µ,m of cell contour (de Harven and Christensen,
1992), was apparently maximum on platelets and served
1195
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Figure 5. High magnification of a megakaryocyte precursor cell showing intense labeling for the CD61 antigen. Note
the higher labeling density on the surface of the adjacent platelet (upper right) .

as a reference to evaluate the level of Gpllla glycoprotein expression on the surface of megakaryocyte precursors. Giant platelets, equally heavily labeled, were
frequently observed. They were somewhat difficult to
distinguish from circulating megakaryocytes, since the
apparent absence of any nuclei could be due to thinsectioning artifacts.
Megakaryocyte precursors were identified by the
presence of either one or more ultrastructural features ,
i.e., (1) alpha granules, (2) demarcation membranes,
and (3) large surface blebs. More primitive cells of that
lineage featured a high nucleo/cytoplasmic ratio and a
predominantly euchromatic nucleus with a large nucleolus. All megakaryocyte precursor cells were found
CD61 positive (Fig. 5), with various degrees of labeling
density. A quantitative analysis was performed in an attempt to establish whether or not the cytoplasmic level
of differentiation correlated with the level of expression
of the glycoprotein on the cell surface. The results of
this analysis were completely negative, indicating that
the presence and/or the number of cytoplasmic differentiation organelles appears independent from the level of

expression of Gpllla on cell surfaces, as previously reported (de Harven and Christensen, 1992), although
platelets and megakaryocytes were always heavily
labeled.
Primitive blasts with a very high N/C ratio and
practically no evidence of cytoplasmic differentiation
were frequently GpIIIa positive (Fig. 6). The gold
markers on these cells were evenly distributed along the
whole contour of these cells and, therefore, do not correspond to focal absorption of platelet membrane fragments as demonstrated by Breton-Gorius et al. (1987) on
the surface of monocytes. These cells would not have
been identified as primitive megakaryoblasts without immunolabeling for GpIIla. Moreover, since the Illa portion of the glycoprotein complex is expressed early in
megakaryocytic differentiation (Koller et al. , 1991), we
probably would have missed identifying these cells had
we used an antibody directed against the entire complex
(CD41 and CD61).
Finally, primitive blasts, very similar to the one
shown in Figure 6, were found unlabeled. One can only
hypothesize that some of these cells probably represent
1196
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6
Figure 6. A primitive megakaryoblast shows weak CD61 labeling (only 9 gold markers can be counted over the entire
cell margin on this figure , a labeling density which is, however, definitely regarded as above non-specific background).
Note the large size of the nucleolus, the predominantly euchromatic nucleus, and the high nucleo-cytoplasmic ratio .

primitive megakaryoblasts. Methods for double irnmunolabeling (de Harven et al., 1990) will be used in further studies to find out whether such cells are CD34
positive and to precisely characterize the ultrastructural
correlations between the (CD34 + /CD61-) and the
(CD34+/CD61 +) and (CD34-/CD61 +) phenotypicdifferentiation steps.

tion of the B-ly7 monoclonal antibody (Poppema et al.,
1989), one would have expected ultrastructural identification of the normal counterpart of hairy cells; yet, to
our knowledge, this has not so far been reported. Our
observation ofB-ly7 positive lymphocytes in one case of
HCL is intriguing because, in one sample from a normal
donor, we did find B-ly7 positive lymphocytes by TEM
and could never confirm the finding by SEM. This apparent discrepancy between TEM and SEM observations
is probably due to the small number of B-ly7 positive
lymphocytes. Of course, these studies should be repeated on larger numbers of normal control samples for
more precise ultrastructural characterization of cells
which are likely to represent the normal counterparts of
hairy cells. Further studies with double labeling for
B-ly7 and B- or T-lymphocyte surface markers will help
to identify the nature of the B-ly7 positive lymphocytes.
Still, if such studies do confirm a lymphocytic derivation
of hairy cells as frequently claimed in the past, we
would still have to understand why HCLs do not respond
to therapeutic protocols that induce renuss10ns in

Discussion

Hairy cell leukemia remains an intriguing disease
for several reasons. The normal counterpart of hairy
cells have not, to our knowledge, been identified ultrastructurally. Hairy cells have never been seen undergoing mitotic division and do not incorporate tritiated
thymidine (Gee T, personal communication, 1992).
They share surface features (Polliack et al., 1974) and
surface markers (Soligo et al., 1985; de Harven et al.,
1992) of lymphocytes and monocytes, and respond well
to several therapeutic protocols which are without benefit in other forms of leukemia. After the characteriza1197
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karyocytes frequently encountered in the peripheral
blood of patients with a large spectrum of malignant diseases. Identifying circulating megakaryocytes was facilitated to an important degree by the demonstration of a
distinct peroxidase activity (platelet peroxidase, PPO) in
platelets and megakaryocytes (Breton-Gorius et al.,
1972, 1984).
In addition, we found no correlation between the
level of expression of the surface glycoprotein Gpllla
and ultrastructural markers of differentiation such as
alpha granules, demarcation membranes and surface
blebs. However, because of the sensitivity and specificity of GpIIla labeling we were able to recognize early
megakaryocyte progenitor circulating cells. These cells
appeared much less differentiated than the PPO positive
MK precursors described by Breton-Gorius and Vainchenker (1986). They are, however, extremely similar
to the "lymphocyte-like" mononuclear GpIIla positive
cells demonstrated by Matolcsy and Majdic (1990).
Further studies will include double labeling for CD34
and GpIIIa to recognize the early steps in the commitment of primitive blasts to the megakaryocytic lineage.
Hopefully, double immunogold labeling using antiGpIIla lgG and biotinylated anti-CD34 monoclonal antibody will soon enable us to analyze the ultrastructure of
primitive cells during the process of loosing CD34 expression and acquiring that of GpIIla. This critical step
in the commitment to megakaryocytic differentiation,
modulated by the synergistic effect of several growth
factors, is under active investigation in other laboratories
(Debili et al., 1993).
In conclusion, two different forms of leukemia in
adult patients, i.e., hairy cell leukemia (HCL) and megakaryocytic leukemia (M7) have been studied by immunoelectron microscopy of peripheral blood leukocytes. In
HCL, electron microscopy provided an important diagnostic confirmation, necessary in view of the very specific response of this disease to certain therapeutic
protocols.
In so called "M7'', electron microscopy of PBLs
demonstrated, in several cases, a spectrum of differentiation probably similar to the megakaryocythemia described many years ago by several authors studying the
peripheral blood of patients with a variety of malignant
conditions, including CML. Therefore, some of these
cases should probably not be diagnosed as "megakaryoblastic" leukemia (M7). Similarly, when the bone marrow is packed with proliferating lymphoblasts, observing
circulating myelocytes or erythroblasts is never interpreted as a need to modify the diagnosis nor to consider
a possible biphenotypic disease. The high degree of sensitivity and specificity of immunogold labeling for the
identification of CD61 on primitive megakaryoblasts
plays a major role in current studies of in vitro and in

lymphoid malignancies.
From the point of view of the ultrastructural hematologist, hairy cells are interesting for two reasons: (1)
their surface morphology is the best target for rapid diagnostic identification under the SEM, and (2) they frequently feature cytoplasmic ribosome-lamellae complexes (RLC). Admittedly\ RLC have been described in
non-HCL hematological disorders (see, Ghadially, 1982,
for a review). However, over the past ten years one of
us (de Harven) has been studying, with the TEM, more
than 500 cases of leukemias and associated disorders
without having ever encountered RLC in non-hairy cell
diseases. This negative report is probably of some consequence in view of the long standing research interest
in HCL of this investigator.
Other remarks concern our GpIIla labeling studies
on megakaryoblastic leukemia (M7). The seven patients
studied had advanced, rapidly progressing disease and
represented a heterogeneous group in which three were
described as chronic myelogenous leukemia (CML) in
blast crisis. Could we confirm, by GpIIla labeling of
PBLs, the existence of a true. megakaryoblastic leukemia
in all cases? The answers are mostly negative, because
we frequently observed a spectrum of differentiation of
megakaryocytic elements which corresponds likely to
some form of extra-medullary megakaryocytopoiesis or
megakaryocythemia in patients with bone marrow extensively invaded by another neoplastic clone.
The presence of megakaryocytes in the peripheral
blood of normal individuals has long been reported
(Efrati and Rozenszajn, 1960; Herbeuval et al., 1962a).
Furthermore, large numbers of megakaryocytes were
found in the peripheral blood in cases of hematopoietic
malignancies, particularly in chronic myelogenous leukemia (CML) as reported by Herbeuval et al. (1962b) using immuno-fluorescence with platelet anti-serum
(Duheille et al., 1962). These observations confirmed
an earlier report by Minot (1922) who had already observed that, in some cases of myelogenous leukemia,
many megakaryocytes appear in the peripheral blood.
Circulating megakaryocyte progenitors (CFU-MK) were
described in 9 out of 10 cases of myelofibrosis (Han et
al., 1988). Moreover, circulating megakaryoblasts were
characterized by immuno-electron microscopy in ten
cases of myeloproliferative diseases (Matolcsy and
Majdic, 1990).
The identification of megakaryocytes and their precursors was a matter of great interest in the 1960's when
many investigators applied the newly discovered methods
of diagnostic cytology in attempts to demonstrate metastasizing cells in the peripheral blood of cancer patients.
Hume et al. (1964), for example, using Millipore filtration and Papanicolaou staining, failed to demonstrate
embolic tumor cells but recognized the number of mega1198
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vivo megakaryocytic differentiation (Zipursky et al.,
1995).
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Discussion with Reviewers
Reviewer I: It would be of interest to document the
precise subcellular distribution of the B-ly7 antibody on
the hairy cell surface which could add to the understanding of the function of the corresponding antigen. For
example, adhesion molecules are often concentrated on
the tip of microvilli.
"
Authors: We are familiar with the frequent concentration of many antigens on surface microvilli . However,
this does not seem to be the case for the antigenic sites
recognized by the B-ly7 or the anti-GpIIIa antibodies.

Reviewer I: Could you give more information on the
patients studied, particularly, the bone marrow and
blood counts?
Authors: A paper is in preparation which will be submitted to a hematology journal and in which additional
clinical data concerning the "Query M7" patients will be
provided. More details on the clinical data of the HCL
patients have already been published (see de Harven et
al. , 1994).

Reviewer I : Megak:aryocyte precursors that display agranules and demarcation membranes are not any more
precursors but simply megak:aryocytes. The number of
cytoplasmic organelles cannot be correlated to cell differentiation; more important is the nucleus-cytoplasmic
ratio, texture of the chromatin, and shape of the nucleus.
Please comment.
Authors: We do not agree with the reviewer's remarks
on terminology: we have seen a-granules and/or demarcation membranes in apparently diploid cells with a relatively high nucleo/cytoplasmic ratio and which should
definitely be classified as megakaryocyte precursors.
J.E. Beesley: In diagnostic testing, control samples are
obviously of great importance. Would the authors
please give details of their positive and negative controls
for their experiments.
Authors: We have never found any CD61 + cells in
any other case of leukemia, not considering platelets, of
course.
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portion seen at higher magnification? It might be useful
to note what 9 particles in one section relate to, roughly,
with respect to the total number of labels over the entire
cell surface, i.e., what would be seen by SEM. What
is the normal "background"?
Authors: First, the question of "normal background".
One of the most significant advantages of immunogold
labeling is its remarkably low non-specific background,
as compared, for example, with techniques of immunoperoxidase. Still in all our immunogold labeling work,
we had to set a threshold of significance. We have always set this, arbitrarily, at 5 gold particles (5 nm) for
the entire cell contour. In the case illustrated in Figure
6, we counted 9 gold markers on the entire cell contour
and, therefore, regarded that cell as B-ly7 positive. We
wish we could be more explicit in terms of these numbers counted with EM as they equate to the entire cell
surface as seen by SEM. Simple extrapolations are impossible, mainly because we used 5 nm gold for TEM
and 30 nm gold for SEM, these two markers having , as
is well-known , very different labeling efficiency.

J.E. Beesley: Would the authors please give an indication of the immunolabeling normally expected with
GPIIIa?
Authors: We have found a considerable variation in the
level of GpIIla labeling in MK precursor cells, and we
could not, therefore, illustrate what should be regarded
as the "normal" level expected in these cells.
A. Liepins: Is there a particular reason why the B-ly7
antibody was selected in these studies instead of HML 1,
Ber-Act 8 and/or LFG 1?
Authors: The reason we have worked with the B-ly7
antibody is simply that it was kindly made available to
us by Dr. S. Poppema. We would be most interested if
the reactivity of hairy cells for HML 1, Ber-Act 8
and/or LFG 1 would receive similar attention in the future, in view of the fact that they all belong to the
CD103 cluster, as recently published (Cepek et al.,
1995). Blocking experiments would be useful in ascertaining whether or not these various antibodies compete
indeed for the same or closely adjacent antigenic sites.
A. Liepins: In the megakaryoblastic leukaemia (M7)
cases, labelling was carried out with anti-GPIIIa
(CD-61) which recognizes fibronectin and vibronectin
receptors on megakaryocytes and platelets. How do
these results contribute to the clinical diagnosis of this
type of leukaemia?
Authors: Labelling with anti-GPIIIa did not contribute
significantly to the diagnosis of M7 leukemia primarily
because, in most of our cases, a broad spectrum of differentiation of CD61 + cells were recognized by TEM,
which is hardly compatible with the identification of leukemic clones. Anti-CD61 labelling made it possible to
recognize megakaryocyte precursor cells which would
have been, otherwise, left unidentified. It helped to
recognize the spectrum of differentiation which frequently characterizes the megakaryocythemia accompanying
some cases of CML and other myeloproliferative disorders. But it did not permit to identify these CD61 +
cells as actually leukemic. In short, our study indicated
that it is far from enough to recognize megakaryocyte
precursor cells on blood films by light microscopy to
consolidate a diagnosis of M7 leukemia and that immunogold-TEM with anti-CD61 can only confirm megakaryocythernia, not the megakaryocytic nature of the disease or of the blast crisis observed in some cases of
CML.
R.M. Albrecht: The authors note cells, as the one
shown in Figure 6, can be found either labeled or unlabeled. They note at higher magnification 9 gold particles are seen on the cell. The authors should make
clear that this is over the entire cell margin, not just the
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